登录 注册 会员服务 联系我们

Advanced Phase I/II Studies of Targeted Gene Delivery In Vivo: Intravenous Rexin-G for Gemcitabine-resistant Metastatic Pancreatic Cancer

  • Published:2010-02 Issue:2 Volume:18 Page:435-441
  • ISSN:1525-0016
  • Container-title:Molecular Therapy
  • language:en
  • Short-container-title:Molecular Therapy

Author:

Chawla Sant P,Chua Victoria S,Fernandez Lita,Quon Dorris,Blackwelder William C,Gordon Erlinda M,Hall Frederick L

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference35 articles.

Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in HIV Gene Therapy;International Journal of Molecular Sciences;2024-02-28

2. Innovative Genoceuticals in Human Gene Therapy Solutions: Challenges and Safe Clinical Trials of Orphan Gene Therapy Products;Current Gene Therapy;2024-02

3. Cancer Drug Products Containing Nano-materials: Key Regulatory Issues;Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective;2023-03-05

4. Therapeutic Nanoparticles: Advantages and Toxicity;Indian Journal of Environment Engineering;2022-05-30

5. Protection is not always a good thing: The immune system’s impact on gene therapy;Genetics and Molecular Biology;2022
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3